Sonoma Pharmaceuticals Inc (SNOA) — Capital Reinvestment Ratio
Sonoma Pharmaceuticals Inc (SNOA) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow ($565.00K) in capital expenditures ($2.00K). See Sonoma Pharmaceuticals Inc balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sonoma Pharmaceuticals Inc Capital Reinvestment Ratio (2013–2013)
This chart tracks Sonoma Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Check Sonoma Pharmaceuticals Inc (SNOA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sonoma Pharmaceuticals Inc (2013–2013)
Year-by-year Capital Reinvestment Ratio for Sonoma Pharmaceuticals Inc from 2013 to 2013. For live market cap and broader valuation context, see market cap of Sonoma Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2013 | 0.22x | $1.15 Million | $257.00K | — |